SCHEMBL22071401

SCHEMBL22071401

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc(-c5ccc6c(ccc7c8ccccc8oc67)c5)cc4)n3)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.41
▸ PGR P06401 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ TSHR P16473 3/20 0.41
▸ HPGD P15428 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ POLB P06746 2/20 0.41
▸ CYP1A1 P04798 4/20 0.40
▸ CYP1B1 Q16678 4/20 0.40
▸ CYP1A2 P05177 3/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ PDE5A O76074 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ ABCB1 P08183 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP19A1 P11511 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2B6 P20813 1/20 0.40
▸ TACR2 P21452 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22879986 1.00 MAPT (0.41) MAPTPGRALDH1A1TSHRHPGD
SCHEMBL22880119 0.97 MAPT (0.41) MAPTPGRALDH1A1TSHRHPGD
SCHEMBL22483255 0.96 PLA2G2A (0.41) MAPTPGRALDH1A1TSHRHPGD
SCHEMBL23134132 0.96 PLA2G2A (0.41) MAPTPGRALDH1A1TSHRHPGD
SCHEMBL22070027 0.96 PLA2G2A (0.41) MAPTPGRALDH1A1TSHRHPGD
SCHEMBL23134249 0.96 PLA2G2A (0.41) MAPTPGRALDH1A1TSHRHPGD
SCHEMBL24634398 0.96 PLA2G2A (0.41) MAPTPGRALDH1A1TSHRHPGD
SCHEMBL22070031 0.96 PLA2G2A (0.41) MAPTPGRALDH1A1TSHRHPGD
SCHEMBL22071478 0.96 PLA2G2A (0.41) MAPTPGRALDH1A1TSHRHPGD
SCHEMBL22071474 0.96 MAPT (0.42) MAPTALDH1A1TSHRHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3664172-B1 COMPOUND FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-09-06 — — EP disclosed
US-20210091314-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2021-03-25 — — US disclosed
EP-3664172-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE Samsung SDI Co., Ltd. (KR) 2020-06-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210091314-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 MAPT 960/4885PGR 2555/4885ALDH1A1 318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback